Advertisement

Altered Growth Phenotype of a Burkitt’s Lymphoma Line Following the Introduction and Stable Expression of the EBNA 2A Gene

  • J. Gordon
  • M. J. Millsum
  • M. Finney
  • J. A. Cairns
  • G. R. Guy
  • C. D. Gregory
  • S. D. Abbot
  • A. B. Rickinson
  • F. Wang
  • E. Kieff
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 141)

Summary

Using recombinant retrovirus-mediated transfer, the coding region for the Epstein-Barr virus-encoded EBNA 2A gene was selectively introduced and stably expressed in the Louckes Burkitt lymphoma cell line. Transfected cells displayed the following altered growth characteristics when compared with the parental line: (i) maintenance of proliferation at reduced serum concentrations, (ii) improved seeding efficiency, (iii) production of a unique growth-enhancing factor, (iv) increased sensitivity to the unique factor. These growth-related changes were accompanied by the appearance of large amounts of soluble CD23 fragments in medium conditioned by Louckes cells expressing EBNA 2A. Tumor-promoting phorbol esters were found to induce similar phenotypic change in the Louckes parental line as seen on the introduction of the EBNA 2A gene. Possible mechanisms by which EBNA 2A provides a growth advantage to B lymphoma cells are discussed.

Keywords

Phorbol Myristic Acetate Burkitt Lymphoma Latent Membrane Protein Soluble CD23 Final 16hr 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cairns J A, Flores-Romo L, Millsum M J, Guy G R, Ledbetter J A, Gillis S, Gordon J (1988) Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40) Eur. J. Immunol. (In press).Google Scholar
  2. Dambaugh T, Wang F, Hennessy K, Woodland E, Rickinson A, Kieff E (1986) Expression of Epstein-Barr virus nuclear protein 2 in rodent cells. J. Virol. 59:453–462.PubMedGoogle Scholar
  3. Gordon J, Ley S C, Melamed M, English L S, Hughes-Jones N C (1984) Immortalised B lymphocytres produce B cell growth factor. Nature (London) 310: 145–147.PubMedCrossRefGoogle Scholar
  4. Gordon J, Walker L, Guy G, Brown G, Rowe M, Rickinson A (1986) Control of human B-lymphocyte replication II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology 58: 591–595.PubMedGoogle Scholar
  5. Gordon J, Webb A J, Guy G R, Walker L (1987) Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate and allosteric mechanism of signalling. Immunology 60: 517–521.PubMedGoogle Scholar
  6. Gregory C D, Murray R J, Edwards C J, Rickinson A B (1988) Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt’s lymphoma underlines tumour cell escape from virus-specific T cell surveillance. J. Exp. Med. (In press).Google Scholar
  7. Kamata J, Takaki K, Hinuma T, Watanabe Y (1981) Protein kinase activity associated with Epstein-Barr virus-determined nuclear antigen. Virology. 113: 512–520.PubMedCrossRefGoogle Scholar
  8. Rickinson A B, Young L S, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310–1317.PubMedGoogle Scholar
  9. Rowe M, Rowe D T, Gregory C D, Young L S, Farrell P J, Rupani H, Rickinson A B (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitts lymphoma cells. EMBO J. 6:2743–2751.PubMedGoogle Scholar
  10. Swendeman S and Thorley-Lawson D A (1987) The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells. EMBO J. 6:1637–1642.PubMedGoogle Scholar
  11. Wang F, Gregory C D, Rowe M, Rickinson A B, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc.Natl.Acad. Sci. USA 84:3452–3456.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1988

Authors and Affiliations

  • J. Gordon
    • 1
  • M. J. Millsum
    • 1
  • M. Finney
    • 1
  • J. A. Cairns
    • 1
  • G. R. Guy
    • 2
  • C. D. Gregory
    • 3
  • S. D. Abbot
    • 3
  • A. B. Rickinson
    • 3
  • F. Wang
    • 4
  • E. Kieff
    • 4
  1. 1.Departments of ImmunologyUniversity of BirminghamBirminghamUK
  2. 2.Departments of BiochemistryUniversity of BirminghamBirminghamUK
  3. 3.Cancer StudiesUniversity of BirminghamBirminghamUK
  4. 4.Brigham HospitalUSA

Personalised recommendations